Russ Mould, AJ Bell's Investment Director, discusses AstraZeneca, due to release full year results on 14 February.
AJ Bell Youinvest Breaking the Mould - AstraZeneca
Russ Mould, AJ Bell's Investment Director, discusses AstraZeneca, due to release full year results on 14 February.
0 Comments